News - Headlands Research

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

About
Our Sites
CROs & Sponsors
Information Hub
- Blog
- Events
- In the Media
- News
- Resources
Careers
Contact

News

June 24, 2025

June 24, 2025

Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity — A Phase 2 Trial

Read More

June 23, 2025

June 23, 2025

CagriSema (Cagrilintide–Semaglutide) in Adults with Overweight or Obesity and Type 2 Diabetes

Read More

May 29, 2025

May 29, 2025

Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial

Read More

April 23, 2025

April 23, 2025

Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes

Read More

March 19, 2025

March 19, 2025

A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

Read More

February 28, 2025

February 28, 2025

Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)

Read More

November 13, 2024

November 13, 2024

Tirzepatide for Obesity Treatment and Diabetes Prevention

Read More

November 4, 2024

November 4, 2024

Headlands Research Acquires Trial Management Associates

Read More

September 19, 2024

September 19, 2024

Headlands Research to Open New Clinical Research Site in El Paso, Texas, Further Commitment to Improving Diversity in Clinical Research

Read More

July 15, 2024

rimegepant

July 15, 2024

Safety of Rimegepant in Adults with Migraine and Cardiovascular Risk Factors: Analysis of a Multicenter, Long‐Term, Open‐Label Study

Read More

Posts pagination

← 1 2 3 … 7 →

130 John F Kennedy Dr STE 203 Lake Worth, FL 33462

© 2026 Headlands Research. | Privacy Policy

Facebook
LinkedIn
Twitter
Instagram